John Arnold Statement on the Passage of HR 3, Lower Drug Costs Now Act of 2019

John Arnold, Founder and Co-Chair of Arnold Ventures, today issued the following statement regarding the passage of H.R. 3, the Lower Drug Costs Now Act of 2019:

For far too long, Americans have been a victim to a drug pricing system that provides neither the access nor affordability they deserve. We applaud Congress for taking positive steps toward lowering drug prices and providing much-needed financial relief for the countless numbers of people who have been harmed by anti-competitive pharmaceutical practices. It takes courage to stand up to Big Pharma and to resist the industry’s scare tactics. We are pleased to see lawmakers stepping up and putting their constituents’ needs first. We look forward to seeing continued legislative movement by the Senate and the White House in the right direction to rein in drug prices. It’s time to get the job done.